Copyright Reports & Markets. All rights reserved.

Global Hepatitis A Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Hepatitis A Vaccine Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Inactivated Vaccine
    • 1.3.3 Live Attenuated Vaccine
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Hepatitis A Vaccine Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Government Institution
    • 1.4.3 Private Sector
    • 1.4.4 Other
  • 1.5 Global Hepatitis A Vaccine Market Size & Forecast
    • 1.5.1 Global Hepatitis A Vaccine Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Hepatitis A Vaccine Sales Quantity (2020-2031)
    • 1.5.3 Global Hepatitis A Vaccine Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 GSK
    • 2.1.1 GSK Details
    • 2.1.2 GSK Major Business
    • 2.1.3 GSK Hepatitis A Vaccine Product and Services
    • 2.1.4 GSK Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 GSK Recent Developments/Updates
  • 2.2 Merck
    • 2.2.1 Merck Details
    • 2.2.2 Merck Major Business
    • 2.2.3 Merck Hepatitis A Vaccine Product and Services
    • 2.2.4 Merck Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Merck Recent Developments/Updates
  • 2.3 Sanofi
    • 2.3.1 Sanofi Details
    • 2.3.2 Sanofi Major Business
    • 2.3.3 Sanofi Hepatitis A Vaccine Product and Services
    • 2.3.4 Sanofi Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Sanofi Recent Developments/Updates
  • 2.4 Sinovac
    • 2.4.1 Sinovac Details
    • 2.4.2 Sinovac Major Business
    • 2.4.3 Sinovac Hepatitis A Vaccine Product and Services
    • 2.4.4 Sinovac Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sinovac Recent Developments/Updates
  • 2.5 Zhejiang Pukang
    • 2.5.1 Zhejiang Pukang Details
    • 2.5.2 Zhejiang Pukang Major Business
    • 2.5.3 Zhejiang Pukang Hepatitis A Vaccine Product and Services
    • 2.5.4 Zhejiang Pukang Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Zhejiang Pukang Recent Developments/Updates
  • 2.6 Changchun Institute of Biological
    • 2.6.1 Changchun Institute of Biological Details
    • 2.6.2 Changchun Institute of Biological Major Business
    • 2.6.3 Changchun Institute of Biological Hepatitis A Vaccine Product and Services
    • 2.6.4 Changchun Institute of Biological Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Changchun Institute of Biological Recent Developments/Updates
  • 2.7 KM Biologics
    • 2.7.1 KM Biologics Details
    • 2.7.2 KM Biologics Major Business
    • 2.7.3 KM Biologics Hepatitis A Vaccine Product and Services
    • 2.7.4 KM Biologics Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 KM Biologics Recent Developments/Updates
  • 2.8 IMBCAMS
    • 2.8.1 IMBCAMS Details
    • 2.8.2 IMBCAMS Major Business
    • 2.8.3 IMBCAMS Hepatitis A Vaccine Product and Services
    • 2.8.4 IMBCAMS Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 IMBCAMS Recent Developments/Updates
  • 2.9 Convac
    • 2.9.1 Convac Details
    • 2.9.2 Convac Major Business
    • 2.9.3 Convac Hepatitis A Vaccine Product and Services
    • 2.9.4 Convac Hepatitis A Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Convac Recent Developments/Updates

3 Competitive Environment: Hepatitis A Vaccine by Manufacturer

  • 3.1 Global Hepatitis A Vaccine Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Hepatitis A Vaccine Revenue by Manufacturer (2020-2025)
  • 3.3 Global Hepatitis A Vaccine Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Hepatitis A Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Hepatitis A Vaccine Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Hepatitis A Vaccine Manufacturer Market Share in 2024
  • 3.5 Hepatitis A Vaccine Market: Overall Company Footprint Analysis
    • 3.5.1 Hepatitis A Vaccine Market: Region Footprint
    • 3.5.2 Hepatitis A Vaccine Market: Company Product Type Footprint
    • 3.5.3 Hepatitis A Vaccine Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Hepatitis A Vaccine Market Size by Region
    • 4.1.1 Global Hepatitis A Vaccine Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Hepatitis A Vaccine Consumption Value by Region (2020-2031)
    • 4.1.3 Global Hepatitis A Vaccine Average Price by Region (2020-2031)
  • 4.2 North America Hepatitis A Vaccine Consumption Value (2020-2031)
  • 4.3 Europe Hepatitis A Vaccine Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Hepatitis A Vaccine Consumption Value (2020-2031)
  • 4.5 South America Hepatitis A Vaccine Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Hepatitis A Vaccine Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Hepatitis A Vaccine Sales Quantity by Type (2020-2031)
  • 5.2 Global Hepatitis A Vaccine Consumption Value by Type (2020-2031)
  • 5.3 Global Hepatitis A Vaccine Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Hepatitis A Vaccine Sales Quantity by Application (2020-2031)
  • 6.2 Global Hepatitis A Vaccine Consumption Value by Application (2020-2031)
  • 6.3 Global Hepatitis A Vaccine Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Hepatitis A Vaccine Sales Quantity by Type (2020-2031)
  • 7.2 North America Hepatitis A Vaccine Sales Quantity by Application (2020-2031)
  • 7.3 North America Hepatitis A Vaccine Market Size by Country
    • 7.3.1 North America Hepatitis A Vaccine Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Hepatitis A Vaccine Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Hepatitis A Vaccine Sales Quantity by Type (2020-2031)
  • 8.2 Europe Hepatitis A Vaccine Sales Quantity by Application (2020-2031)
  • 8.3 Europe Hepatitis A Vaccine Market Size by Country
    • 8.3.1 Europe Hepatitis A Vaccine Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Hepatitis A Vaccine Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Hepatitis A Vaccine Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Hepatitis A Vaccine Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Hepatitis A Vaccine Market Size by Region
    • 9.3.1 Asia-Pacific Hepatitis A Vaccine Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Hepatitis A Vaccine Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Hepatitis A Vaccine Sales Quantity by Type (2020-2031)
  • 10.2 South America Hepatitis A Vaccine Sales Quantity by Application (2020-2031)
  • 10.3 South America Hepatitis A Vaccine Market Size by Country
    • 10.3.1 South America Hepatitis A Vaccine Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Hepatitis A Vaccine Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Hepatitis A Vaccine Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Hepatitis A Vaccine Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Hepatitis A Vaccine Market Size by Country
    • 11.3.1 Middle East & Africa Hepatitis A Vaccine Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Hepatitis A Vaccine Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Hepatitis A Vaccine Market Drivers
  • 12.2 Hepatitis A Vaccine Market Restraints
  • 12.3 Hepatitis A Vaccine Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Hepatitis A Vaccine and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Hepatitis A Vaccine
  • 13.3 Hepatitis A Vaccine Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Hepatitis A Vaccine Typical Distributors
  • 14.3 Hepatitis A Vaccine Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Hepatitis A Vaccine market size was valued at US$ 772 million in 2024 and is forecast to a readjusted size of USD 897 million by 2031 with a CAGR of 2.2% during review period.
    Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year. Two types of HAV vaccines are currently available internationally: 1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml). 2. Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
    The Hepatitis A vaccine market is primarily driven by the increasing awareness of hepatitis prevention, coupled with growing vaccination programs initiated by governments and health organizations globally. As hepatitis A is a highly contagious liver infection, the rising incidence of outbreaks, especially in developing regions, is pushing demand for vaccines. Moreover, the expanding travel industry, where travelers are required to be vaccinated for hepatitis A when visiting certain high-risk regions, is further bolstering market growth. In addition, advancements in vaccine technology and the increasing availability of combination vaccines are also contributing factors. However, the market faces several challenges. One of the primary challenges is the high cost of vaccines, especially in low-income regions, limiting access for vulnerable populations. Additionally, the lack of infrastructure and healthcare facilities in remote areas poses a significant barrier to widespread vaccine distribution. In certain regions, vaccine hesitancy due to misinformation and fear of side effects also hampers market growth, making public health education and outreach essential to overcoming these obstacles.
    Global hepatitis a vaccine key players include GSK, Merck, Sanofi, etc. Global top 5 manufacturers hold a share over 80%. Asia-Pacific is the largest market, with a share over 38%, followed by North America and Europe , both have a share over 54%. In terms of product, inactivated vaccine is the largest segment, with a share about 85%. And in terms of application, the largest application is government institution, followed by private sector, etc.
    This report is a detailed and comprehensive analysis for global Hepatitis A Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Hepatitis A Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2020-2031
    Global Hepatitis A Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2020-2031
    Global Hepatitis A Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Unit), and average selling prices (USD/Unit), 2020-2031
    Global Hepatitis A Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Unit), and ASP (USD/Unit), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Hepatitis A Vaccine
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Hepatitis A Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GSK, Merck, Sanofi, Sinovac, Zhejiang Pukang, Changchun Institute of Biological, KM Biologics, IMBCAMS, Convac, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Hepatitis A Vaccine market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Inactivated Vaccine
    Live Attenuated Vaccine
    Market segment by Application
    Government Institution
    Private Sector
    Other
    Major players covered
    GSK
    Merck
    Sanofi
    Sinovac
    Zhejiang Pukang
    Changchun Institute of Biological
    KM Biologics
    IMBCAMS
    Convac
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Hepatitis A Vaccine product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Hepatitis A Vaccine, with price, sales quantity, revenue, and global market share of Hepatitis A Vaccine from 2020 to 2025.
    Chapter 3, the Hepatitis A Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Hepatitis A Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Hepatitis A Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Hepatitis A Vaccine.
    Chapter 14 and 15, to describe Hepatitis A Vaccine sales channel, distributors, customers, research findings and conclusion.

    Buy now